Healthcare entity
Source depth averages 7.7 original sources per story, versus 3.4 across the same-window beat baseline. Abbott is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories. The 188-day window averages about 0.1 stories each week. The average consequence score is 6, matching the 6 beat baseline for this window.
Last mentioned: Sep 2, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Source depth averages 7.7 original sources per story, versus 3.4 across the same-window beat baseline. Abbott is the most frequent co-covered peer, appearing in 1 of the 3 tracked stories. The 188-day window averages about 0.1 stories each week. The average consequence score is 6, matching the 6 beat baseline for this window. Coverage clusters in health-it, which accounts for 1 of those 3, with the remainder spread across 2 other categories. We currently track 3 Healthcare stories that mention NovoCure, published between February 27, 2026 and September 2, 2026.
Computed from the 3 stories linked to this entity, with beat comparisons drawn from all 1095 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NovoCure. Shared-story counts are live from our verified record — not editorial picks.
Public breach disclosure
Novocure publicly reported the cyberattack, disclosing that internal records of more than 1,400 U.S. patients were exposed.
Unauthorized access occurs
Novocure says unauthorized access to certain information systems occurred in mid-August 2026, exposing internal patient records.
Incident response activated
Novocure activated its cybersecurity response plan, implemented containment measures, and initiated an internal investigation.
Novocure disclosed a mid-August cyberattack that exposed internal records of more than 1,400 U.S. oncology patients, along with provider contact details and employee job titles. The company said treatment devices were not accessed and that it expects no material financial impact. For healthcare IT and compliance leaders, the incident is another compelling case study in breach response, data classification, and regulatory risk.
Source: CNA
Amgen and NovoCure represent two extremes in healthcare delivery: a wholesale-dependent drug giant and a patient-centric device innovator. The comparison reveals how direct-to-patient models are reshaping oncology treatment accessibility and reimbursement dynamics.
The fourth quarter of 2025 revealed a decisive shift in the healthcare technology sector toward AI-integrated diagnostics and high-margin specialized therapies. Leading the charge, Butterfly Network reported record revenue growth driven by its AI-embedded strategy, while Solventum navigated its post-spin-off stabilization phase with resilient organic growth.
NovoCure is linked from 3 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
